Related Experiment Videos
Nitric oxide donor drugs: current status and future trends
1Centre for Cardiovascular Science, Division of Biomedical & Clinical Laboratory Sciences, University of Edinburgh, Edinburgh, Scotland, UK. ian.megson@ed.ac.uk
Expert Opinion on Investigational Drugs
|May 9, 2002
Summary
Nitric oxide (NO) is vital for cardiovascular health. This review explores novel nitric oxide donor drugs, an attractive therapeutic option for cardiovascular diseases, moving beyond traditional nitrates.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Biomedical Engineering
Background:
- Nitric oxide (NO) synthesized by endothelial cells is crucial for cardiovascular health.
- Reduced NO availability contributes to cardiovascular disease initiation and progression.
- Supplementary NO delivery is a promising therapeutic strategy.
Purpose of the Study:
- To review novel advances in nitric oxide donor drug development.
- To explore future directions in therapeutic NO delivery.
- To discuss alternatives to traditional organic nitrates.
Main Methods:
- Literature review of scientific publications.
- Analysis of recent research on NO donor drug classes.
- Synthesis of findings on therapeutic potential and limitations.
Main Results:
- Organic nitrates offer symptomatic relief but have limitations.
- Emerging NO donor classes provide alternative therapeutic avenues.
- Novel drug development focuses on enhanced NO delivery and efficacy.
Conclusions:
- Nitric oxide donor drugs are a key area for cardiovascular disease management.
- Continued research into novel NO donors holds significant therapeutic promise.
- Future directions include optimizing delivery and targeting of NO-releasing agents.